Wenying Yang Selected Research

Wenying Yang Research Topics

Disease

71	Type 2 Diabetes Mellitus (MODY) 11/2022 - 05/2008
14	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 05/2008
13	Body Weight (Weight, Body) 01/2021 - 04/2012
7	Cardiovascular Diseases (Cardiovascular Disease) 02/2022 - 04/2012
7	Weight Gain 01/2022 - 05/2008
7	Obesity 01/2022 - 12/2002
6	Hyperglycemia 01/2021 - 01/2014
6	Insulin Resistance 12/2018 - 04/2014
5	Albuminuria 01/2021 - 07/2014
5	Glucose Intolerance 11/2017 - 03/2010
4	Prediabetic State (Prediabetes) 01/2019 - 03/2010
3	Diabetes Mellitus 11/2022 - 01/2019
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2020 - 01/2017
3	Hypertension (High Blood Pressure) 11/2013 - 01/2013
2	Nausea 01/2022 - 01/2021
2	Abdominal Obesity 01/2018 - 07/2014
2	Urinary Tract Infections (Urinary Tract Infection) 08/2017 - 11/2016
2	Infections 08/2017 - 11/2016
2	Weight Loss (Weight Reduction) 11/2016 - 01/2012
1	Pulmonary Tuberculosis 01/2021
1	Vomiting 01/2021
1	Neoplasms (Cancer) 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Kidney Diseases (Kidney Disease) 04/2020
1	Heart Failure 04/2020
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Arthritis (Polyarthritis) 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Hemochromatosis (Bronze Diabetes) 01/2019
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Cardiomyopathies (Cardiomyopathy) 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2019
1	Coronary Disease (Coronary Heart Disease) 11/2017
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 11/2017
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2015
1	Proteinuria 01/2015
1	Overweight 01/2014
1	Drug-Related Side Effects and Adverse Reactions 01/2014
1	Dyslipidemias (Dyslipidemia) 01/2013

Drug/Important Bio-Agent (IBA)

36	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 12/2002
27	Insulin (Novolin)FDA Link 11/2022 - 05/2008
18	Metformin (Glucophage)FDA LinkGeneric 11/2022 - 11/2011
13	Acarbose FDA LinkGeneric 01/2021 - 01/2014
12	Hypoglycemic Agents (Hypoglycemics)IBA 11/2022 - 04/2012
11	Blood Glucose (Blood Sugar)IBA 11/2022 - 05/2008
10	Insulin Glargine (Lantus)FDA Link 01/2022 - 04/2012
10	insulin aspart protamine drug combination 30:70 insulin aspartIBA 04/2019 - 05/2008
9	Pharmaceutical PreparationsIBA 01/2022 - 03/2012
5	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 01/2014
5	LipidsIBA 01/2019 - 04/2012
4	CreatinineIBA 04/2020 - 04/2016
4	AlbuminsIBA 04/2020 - 04/2016
3	Insulin Aspart (NovoLog)FDA Link 11/2022 - 11/2013
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 01/2012
3	Sitagliptin Phosphate (Januvia)FDA Link 01/2019 - 01/2009
3	dapagliflozinIBA 07/2018 - 11/2016
3	GlucosidasesIBA 11/2017 - 01/2014
3	Insulin Detemir (Levemir)FDA Link 07/2015 - 11/2013
2	insulin aspart drug combination insulin degludecIBA 02/2022 - 01/2019
2	lixisenatideIBA 01/2022 - 01/2018
2	DorzagliatinIBA 01/2022 - 01/2022
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2018
2	LinagliptinIBA 01/2021 - 04/2020
2	Therapeutic UsesIBA 05/2019 - 01/2014
2	Hemoglobins (Hemoglobin)IBA 01/2016 - 01/2014
2	ORALIT (ORS)IBA 01/2014 - 01/2013
2	saxagliptin FDA Link 03/2012 - 11/2011
1	Glucagon Receptors (Glucagon Receptor)IBA 01/2022
1	mazdutideIBA 01/2022
1	dulaglutideIBA 01/2022
1	polyethylene glycol loxenatideIBA 01/2021
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2021
1	Glucagon (Glukagon)FDA Link 01/2021
1	P-2 (P 2)IBA 01/2019
1	Liraglutide FDA Link 01/2019
1	AutoantibodiesIBA 01/2019
1	IronIBA 01/2019
1	Nonsense Codon (Nonsense Mutation)IBA 01/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019
1	Insulin Lispro (Humalog)FDA Link 06/2018
1	InsulinsIBA 06/2018
1	HDL CholesterolIBA 01/2018
1	Isophane Insulin (NPH Insulin)FDA Link 01/2017
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 01/2017
1	Sodium-Glucose Transport ProteinsIBA 11/2016
1	insulin degludecIBA 06/2016
1	Biomarkers (Surrogate Marker)IBA 09/2015
1	VildagliptinIBA 03/2015
1	glimepiride (Amarel)FDA LinkGeneric 03/2015
1	4-toluenesulfonyl fluoride (TSF)IBA 01/2015
1	tangshenIBA 01/2015
1	LDL CholesterolIBA 09/2014
1	serine racemaseIBA 05/2014
1	Alanine Transaminase (SGPT)IBA 01/2013

Therapy/Procedure

19	Glycemic Control 11/2022 - 01/2009
18	Therapeutics 01/2022 - 09/2012
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2012
2	Secondary Prevention 11/2017 - 12/2014
1	Artificial Pancreas 07/2020